Home › Shire says FDA declines to approve eye drug Lifitegrast
 

Keywords :   


Shire says FDA declines to approve eye drug Lifitegrast

2015-10-17 08:11:06| Biotech - Topix.net

The U.S. Food and Drug Administration notified Shire Plc it will not approve its eye drug Lifitegrast, the company said on Friday, adding that the U.S. health regulator recommended the company conduct additional clinical studies. The news comes over a week before the FDA was supposed to make a decision on Lifitegrast on Oct 25. Shire said it received a complete response letter, which the FDA sends to let a drug developer know a marketing application will not be approved in its present form.

Tags: eye drug approve fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
More »